Global and United States Proprotein Convertase Subtilisin/Kexin Type 9 Market Insights, Forecast to 2026

Global and United States Proprotein Convertase Subtilisin/Kexin Type 9 Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction
1.2 Market Segments
1.3 Key Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth Rate by Type
1.4.2 SX-PCK9
1.4.3 O-304
1.4.4 K-312
1.4.5 BLSM-201
1.4.6 DCRPCSK-9
1.4.7 Others
1.5 Market by Application
1.5.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth Rate by Application
1.5.2 Cardiovascular Disease
1.5.3 Homozugous Familial Hyperchalesterolemia
1.5.4 Liver Disease
1.5.5 Metabolic Syndrome
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size, Estimates and Forecasts
2.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue 2015-2026
2.1.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales 2015-2026
2.2 Global Proprotein Convertase Subtilisin/Kexin Type 9, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Proprotein Convertase Subtilisin/Kexin Type 9 Historical Market Size by Region (2015-2020)
2.3.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Proprotein Convertase Subtilisin/Kexin Type 9 Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Region (2021-2026)
2.4.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Region (2021-2026)
3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Competitor Landscape by Players
3.1 Global Top Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Manufacturers
3.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Manufacturers (2015-2020)
3.1.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Manufacturers (2015-2020)
3.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturers by Revenue
3.2.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Manufacturers (2015-2020)
3.2.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Proprotein Convertase Subtilisin/Kexin Type 9 Revenue in 2019
3.2.5 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Price by Manufacturers
3.4 Global Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturing Base Distribution, Product Types
3.4.1 Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Proprotein Convertase Subtilisin/Kexin Type 9 Product Type
3.4.3 Date of International Manufacturers Enter into Proprotein Convertase Subtilisin/Kexin Type 9 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2015-2020)
4.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Type (2015-2020)
4.1.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Type (2015-2020)
4.1.3 Proprotein Convertase Subtilisin/Kexin Type 9 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast by Type (2021-2026)
4.2.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Type (2021-2026)
4.2.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Type (2021-2026)
4.2.3 Proprotein Convertase Subtilisin/Kexin Type 9 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2015-2020)
5.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Application (2015-2020)
5.1.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Application (2015-2020)
5.1.3 Proprotein Convertase Subtilisin/Kexin Type 9 Price by Application (2015-2020)
5.2 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast by Application (2021-2026)
5.2.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Application (2021-2026)
5.2.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Application (2021-2026)
5.2.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Proprotein Convertase Subtilisin/Kexin Type 9 Market Size YoY Growth 2015-2026
6.1.1 United States Proprotein Convertase Subtilisin/Kexin Type 9 Sales YoY Growth 2015-2026
6.1.2 United States Proprotein Convertase Subtilisin/Kexin Type 9 Revenue YoY Growth 2015-2026
6.1.3 United States Proprotein Convertase Subtilisin/Kexin Type 9 Market Share in Global Market 2015-2026
6.2 United States Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Players (International and Local Players)
6.2.1 United States Top Proprotein Convertase Subtilisin/Kexin Type 9 Players by Sales (2015-2020)
6.2.2 United States Top Proprotein Convertase Subtilisin/Kexin Type 9 Players by Revenue (2015-2020)
6.3 United States Proprotein Convertase Subtilisin/Kexin Type 9 Historic Market Review by Type (2015-2020)
6.3.1 United States Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Type (2015-2020)
6.3.2 United States Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Type (2015-2020)
6.3.3 United States Proprotein Convertase Subtilisin/Kexin Type 9 Price by Type (2015-2020)
6.4 United States Proprotein Convertase Subtilisin/Kexin Type 9 Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Type (2021-2026)
6.4.2 United States Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Type (2021-2026)
6.4.3 United States Proprotein Convertase Subtilisin/Kexin Type 9 Price Forecast by Type (2021-2026)
6.5 United States Proprotein Convertase Subtilisin/Kexin Type 9 Historic Market Review by Application (2015-2020)
6.5.1 United States Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Application (2015-2020)
6.5.2 United States Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Application (2015-2020)
6.5.3 United States Proprotein Convertase Subtilisin/Kexin Type 9 Price by Application (2015-2020)
6.6 United States Proprotein Convertase Subtilisin/Kexin Type 9 Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Application (2021-2026)
6.6.2 United States Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Forecast by Application (2021-2026)
6.6.3 United States Proprotein Convertase Subtilisin/Kexin Type 9 Price Forecast by Application (2021-2026)
7 North America
7.1 North America Proprotein Convertase Subtilisin/Kexin Type 9 Market Size YoY Growth 2015-2026
7.2 North America Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Country
7.2.1 North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country (2015-2020)
7.2.2 North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size YoY Growth 2015-2026
8.2 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Country
8.2.1 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country
8.2.2 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Market Size YoY Growth 2015-2026
9.2 Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Country
9.2.1 Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Region (2015-2020)
9.2.2 Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Market Size YoY Growth 2015-2026
10.2 Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Country
10.2.1 Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country
10.2.2 Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Facts & Figures by Country
11.2.1 Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country
11.2.2 Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 AFFiRiS AG
12.1.1 AFFiRiS AG Corporation Information
12.1.2 AFFiRiS AG Description and Business Overview
12.1.3 AFFiRiS AG Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
12.1.5 AFFiRiS AG Recent Development
12.2 Betagenon AB
12.2.1 Betagenon AB Corporation Information
12.2.2 Betagenon AB Description and Business Overview
12.2.3 Betagenon AB Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
12.2.5 Betagenon AB Recent Development
12.3 Bioleaders Corp
12.3.1 Bioleaders Corp Corporation Information
12.3.2 Bioleaders Corp Description and Business Overview
12.3.3 Bioleaders Corp Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
12.3.5 Bioleaders Corp Recent Development
12.4 BioLingus AG
12.4.1 BioLingus AG Corporation Information
12.4.2 BioLingus AG Description and Business Overview
12.4.3 BioLingus AG Sales, Revenue and Gross Margin (2015-2020)
12.4.4 BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
12.4.5 BioLingus AG Recent Development
12.5 Catabasis Pharmaceuticals Inc
12.5.1 Catabasis Pharmaceuticals Inc Corporation Information
12.5.2 Catabasis Pharmaceuticals Inc Description and Business Overview
12.5.3 Catabasis Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
12.5.5 Catabasis Pharmaceuticals Inc Recent Development
12.6 Dicerna Pharmaceuticals Inc
12.6.1 Dicerna Pharmaceuticals Inc Corporation Information
12.6.2 Dicerna Pharmaceuticals Inc Description and Business Overview
12.6.3 Dicerna Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
12.6.5 Dicerna Pharmaceuticals Inc Recent Development
12.7 Eli Lilly and Co
12.7.1 Eli Lilly and Co Corporation Information
12.7.2 Eli Lilly and Co Description and Business Overview
12.7.3 Eli Lilly and Co Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
12.7.5 Eli Lilly and Co Recent Development
12.8 Ensemble Therapeutics Corp
12.8.1 Ensemble Therapeutics Corp Corporation Information
12.8.2 Ensemble Therapeutics Corp Description and Business Overview
12.8.3 Ensemble Therapeutics Corp Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
12.8.5 Ensemble Therapeutics Corp Recent Development
12.9 Kowa Co Ltd
12.9.1 Kowa Co Ltd Corporation Information
12.9.2 Kowa Co Ltd Description and Business Overview
12.9.3 Kowa Co Ltd Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
12.9.5 Kowa Co Ltd Recent Development
12.10 Novartis AG
12.10.1 Novartis AG Corporation Information
12.10.2 Novartis AG Description and Business Overview
12.10.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
12.10.5 Novartis AG Recent Development
12.11 AFFiRiS AG
12.11.1 AFFiRiS AG Corporation Information
12.11.2 AFFiRiS AG Description and Business Overview
12.11.3 AFFiRiS AG Sales, Revenue and Gross Margin (2015-2020)
12.11.4 AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Products Offered
12.11.5 AFFiRiS AG Recent Development
12.12 Regeneron Pharmaceuticals Inc
12.12.1 Regeneron Pharmaceuticals Inc Corporation Information
12.12.2 Regeneron Pharmaceuticals Inc Description and Business Overview
12.12.3 Regeneron Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Regeneron Pharmaceuticals Inc Products Offered
12.12.5 Regeneron Pharmaceuticals Inc Recent Development
12.13 Serometrix LLC
12.13.1 Serometrix LLC Corporation Information
12.13.2 Serometrix LLC Description and Business Overview
12.13.3 Serometrix LLC Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Serometrix LLC Products Offered
12.13.5 Serometrix LLC Recent Development
12.14 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
12.14.1 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Corporation Information
12.14.2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Description and Business Overview
12.14.3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Products Offered
12.14.5 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Recent Development
12.15 The Medicines Company
12.15.1 The Medicines Company Corporation Information
12.15.2 The Medicines Company Description and Business Overview
12.15.3 The Medicines Company Sales, Revenue and Gross Margin (2015-2020)
12.15.4 The Medicines Company Products Offered
12.15.5 The Medicines Company Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Proprotein Convertase Subtilisin/Kexin Type 9 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Proprotein Convertase Subtilisin/Kexin Type 9 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Proprotein Convertase Subtilisin/Kexin Type 9 Market Segments
Table 2. Ranking of Global Top Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of SX-PCK9
Table 5. Major Manufacturers of O-304
Table 6. Major Manufacturers of K-312
Table 7. Major Manufacturers of BLSM-201
Table 8. Major Manufacturers of DCRPCSK-9
Table 9. Major Manufacturers of Others
Table 10. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Regions (2015-2020)
Table 14. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Forecast by Region (2021-2026) (K Pcs)
Table 16. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Manufacturers (2015-2020)
Table 18. Global Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Proprotein Convertase Subtilisin/Kexin Type 9 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Proprotein Convertase Subtilisin/Kexin Type 9 as of 2019)
Table 20. Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Proprotein Convertase Subtilisin/Kexin Type 9 Price (2015-2020) (USD/Pcs)
Table 23. Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Proprotein Convertase Subtilisin/Kexin Type 9 Product Type
Table 25. Date of International Manufacturers Enter into Proprotein Convertase Subtilisin/Kexin Type 9 Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Type (2015-2020) (K Pcs)
Table 28. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Type (2015-2020)
Table 29. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Share by Type (2015-2020)
Table 31. Proprotein Convertase Subtilisin/Kexin Type 9 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Type (2021-2026)
Table 33. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Application (2015-2020) (K Pcs)
Table 34. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Application (2015-2020)
Table 35. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Application (2021-2026)
Table 36. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share Forecast by Application (2021-2026)
Table 37. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Application (2015-2020) (US$ Million)
Table 38. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share Forecast by Application (2021-2026)
Table 39. United States Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs) of Key Companies (2015-2020)
Table 40. United States Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Company (2015-2020)
Table 41. United States Proprotein Convertase Subtilisin/Kexin Type 9 Revenue (US$ Million) by Company (2015-2020)
Table 42. United States Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs) by Type (2015-2020)
Table 43. United States Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Type (2015-2020)
Table 44. United States Proprotein Convertase Subtilisin/Kexin Type 9 Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. United States Proprotein Convertase Subtilisin/Kexin Type 9 Price (K Pcs) by Type (2015-2020)
Table 46. United States Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs) by Type (2021-2026)
Table 47. United States Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Type (2021-2026)
Table 48. United States Proprotein Convertase Subtilisin/Kexin Type 9 Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. United States Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Share by Type (2021-2026)
Table 50. United States Proprotein Convertase Subtilisin/Kexin Type 9 Price (K Pcs) by Type (2021-2026)
Table 51. United States Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs) by Application (2015-2020)
Table 52. United States Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Application (2015-2020)
Table 53. United States Proprotein Convertase Subtilisin/Kexin Type 9 Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. United States Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs) by Application (2021-2026)
Table 55. United States Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Application (2021-2026)
Table 56. United States Proprotein Convertase Subtilisin/Kexin Type 9 Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. United States Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Share by Application (2021-2026)
Table 58. North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country (2015-2020) (K Pcs)
Table 59. North America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country (2015-2020)
Table 60. North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country (2015-2020) (US$ Million)
Table 61. North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country (2015-2020)
Table 62. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country (2015-2020) (K Pcs)
Table 63. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country (2015-2020)
Table 64. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Region (2015-2020) (K Pcs)
Table 67. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Region (2015-2020)
Table 70. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country (2015-2020) (K Pcs)
Table 71. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales by Country (2015-2020) (K Pcs)
Table 75. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Country (2015-2020)
Table 78. AFFiRiS AG Corporation Information
Table 79. AFFiRiS AG Description and Business Overview
Table 80. AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Product
Table 82. AFFiRiS AG Recent Development
Table 83. Betagenon AB Corporation Information
Table 84. Betagenon AB Description and Business Overview
Table 85. Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Betagenon AB Product
Table 87. Betagenon AB Recent Development
Table 88. Bioleaders Corp Corporation Information
Table 89. Bioleaders Corp Description and Business Overview
Table 90. Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Bioleaders Corp Product
Table 92. Bioleaders Corp Recent Development
Table 93. BioLingus AG Corporation Information
Table 94. BioLingus AG Description and Business Overview
Table 95. BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. BioLingus AG Product
Table 97. BioLingus AG Recent Development
Table 98. Catabasis Pharmaceuticals Inc Corporation Information
Table 99. Catabasis Pharmaceuticals Inc Description and Business Overview
Table 100. Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Catabasis Pharmaceuticals Inc Product
Table 102. Catabasis Pharmaceuticals Inc Recent Development
Table 103. Dicerna Pharmaceuticals Inc Corporation Information
Table 104. Dicerna Pharmaceuticals Inc Description and Business Overview
Table 105. Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Dicerna Pharmaceuticals Inc Product
Table 107. Dicerna Pharmaceuticals Inc Recent Development
Table 108. Eli Lilly and Co Corporation Information
Table 109. Eli Lilly and Co Description and Business Overview
Table 110. Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Eli Lilly and Co Product
Table 112. Eli Lilly and Co Recent Development
Table 113. Ensemble Therapeutics Corp Corporation Information
Table 114. Ensemble Therapeutics Corp Description and Business Overview
Table 115. Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Ensemble Therapeutics Corp Product
Table 117. Ensemble Therapeutics Corp Recent Development
Table 118. Kowa Co Ltd Corporation Information
Table 119. Kowa Co Ltd Description and Business Overview
Table 120. Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Kowa Co Ltd Product
Table 122. Kowa Co Ltd Recent Development
Table 123. Novartis AG Corporation Information
Table 124. Novartis AG Description and Business Overview
Table 125. Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Novartis AG Product
Table 127. Novartis AG Recent Development
Table 128. Pfizer Inc Corporation Information
Table 129. Pfizer Inc Description and Business Overview
Table 130. Pfizer Inc Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Pfizer Inc Product
Table 132. Pfizer Inc Recent Development
Table 133. Regeneron Pharmaceuticals Inc Corporation Information
Table 134. Regeneron Pharmaceuticals Inc Description and Business Overview
Table 135. Regeneron Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Regeneron Pharmaceuticals Inc Product
Table 137. Regeneron Pharmaceuticals Inc Recent Development
Table 138. Serometrix LLC Corporation Information
Table 139. Serometrix LLC Description and Business Overview
Table 140. Serometrix LLC Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 141. Serometrix LLC Product
Table 142. Serometrix LLC Recent Development
Table 143. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Corporation Information
Table 144. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Description and Business Overview
Table 145. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 146. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Product
Table 147. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Recent Development
Table 148. The Medicines Company Corporation Information
Table 149. The Medicines Company Description and Business Overview
Table 150. The Medicines Company Proprotein Convertase Subtilisin/Kexin Type 9 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 151. The Medicines Company Product
Table 152. The Medicines Company Recent Development
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Market Risks
Table 156. Main Points Interviewed from Key Proprotein Convertase Subtilisin/Kexin Type 9 Players
Table 157. Proprotein Convertase Subtilisin/Kexin Type 9 Customers List
Table 158. Proprotein Convertase Subtilisin/Kexin Type 9 Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Proprotein Convertase Subtilisin/Kexin Type 9 Product Picture
Figure 2. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Type in 2020 & 2026
Figure 3. SX-PCK9 Product Picture
Figure 4. O-304 Product Picture
Figure 5. K-312 Product Picture
Figure 6. BLSM-201 Product Picture
Figure 7. DCRPCSK-9 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Application in 2020 & 2026
Figure 10. Cardiovascular Disease
Figure 11. Homozugous Familial Hyperchalesterolemia
Figure 12. Liver Disease
Figure 13. Metabolic Syndrome
Figure 14. Others
Figure 15. Proprotein Convertase Subtilisin/Kexin Type 9 Report Years Considered
Figure 16. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2015-2026 (US$ Million)
Figure 17. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales 2015-2026 (K Pcs)
Figure 18. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Region (2015-2020)
Figure 20. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Market Share by Region in 2019
Figure 21. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Region (2015-2020)
Figure 22. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Region in 2019
Figure 23. Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Proprotein Convertase Subtilisin/Kexin Type 9 Revenue in 2019
Figure 25. Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Proprotein C

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs